Tiziana Life Sciences ratios data for the quarter ended Dec 2025. These financial ratios cover 16 quarters of results from Jun 2018 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2018 | Dec2018 | Jun2019 | Dec2019 | Jun2020 | Dec2020 | Jun2021 | Dec2021 | Jun2022 | Dec2022 | Jun2023 | Dec2023 | Jun2024 | Dec2024 | Jun2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Efficiency | ||||||||||||||||
| Assets AverageAssets Avg. | 2.11M | 4.39M | 4.85M | 2.51M | 7.68M | 41.84M | 64.26M | 53.35M | 41.98M | 30.80M | 21.95M | 14.80M | 11.57M | 11.12M | 13.94M | 14.05M |
| Invested CapitalInvested Cap. | 0.98M | -4.15M | -8.81M | -4.48M | 64.10M | -15.45M | 42.63M | |||||||||
| Leverage & Solvency | ||||||||||||||||
| Debt Ratio | 0.06 | 0.19 | 0.25 | 0.03 | 0.02 | 0.03 | 0.03 | |||||||||
| Valuation | ||||||||||||||||
| Price to BookP/B | 384.47 | -42.17 | -15.71 | -71.90 | 6.30 | -26.86 | 2.38 | -9.26 | 3.14 | -8.07 | 10.43 | -20.07 | 19.82 | -31.27 | 0.00M | |
| Enterprise Value | 197.97M | 195.94M | 147.39M | 342.26M | 327.29M | 404.06M | 56.00M | 50.16M | 43.24M | 62.95M | 56.55M | 93.71M | 74.30M | 168.86M | 175.55M | |
| Market Capitalization | 203.33M | 196.51M | 147.59M | 351.20M | 393.12M | 457.34M | 98.18M | 76.70M | 61.36M | 69.55M | 57.73M | 94.84M | 78.02M | 176.11M | 179.56M |